SAN ANTONIO (MedPage Today) -- A humanized monoclonal antibody against nerve growth factor demonstrated efficacy in three chronic pain syndromes, according to a summary of small studies reported as an abstract here...

AAPM: Nerve Growth Factor Antibody May Reduce Pain (click here for the full article at MedPage Today)